Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sight Sciences, Inc.SGHT · Entity 5537 | Chief Operating Officer | October 01, 2024 | October 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sight Sciences, Inc.
Report date October 01, 2024 · Filed October 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 254,826 |
Reported balance
After 2024-10-01 transaction · row 1
1 source rowRow 1 · 2024-10-01 · Sale · Disposed 3,403 · Balance 254,826 F1: Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2024 Filed Oct 3, 2024 21:52 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | SaleCommon Stock | 3,403 | $6.08 | $20,690.24 |
DisclosureSEC source: 0000950170-24-112703 · ownership.xml · nonDerivative · entry 1 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,826 F1 · shares: Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 19:52 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | SaleCommon Stock | 3,525 | $6.21 | $21,897.30 |
DisclosureSEC source: 0000950170-24-081727 · ownership.xml · nonDerivative · entry 1 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,229 F1 · shares: Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Read SEC document |
| April 03, 2024 Filed Apr 4, 2024 19:24 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | SaleCommon Stock | 3,414 | $5.08 | $17,339.71 |
DisclosureSEC source: 0000950170-24-041981 · ownership.xml · nonDerivative · entry 1 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,754 F1 · shares: Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:38 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 151,869 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016706 · ownership.xml · nonDerivative · entry 1 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,168 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing March 31, 2024 and continuing through December 31, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $650,000 divided by the closing price of the Common Stock on the grant date, which was February 14, 2024. The RSUs have no expiration date. F2 · balance_after: Includes 12,564 shares of Common Stock issuable upon the Reporting Person's exercise of options that shall vest within 60 days of the date hereof subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| January 17, 2024 Filed Jan 19, 2024 16:28 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | SaleCommon Stock | 5,443 | $5.16 | $28,107.65 |
DisclosureSEC source: 0000950170-24-005805 · ownership.xml · nonDerivative · entry 1 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,735 F1 · shares: Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 19:37 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Tax withholdingCommon Stock | 2,464 | $5.17 | $12,743.81 |
DisclosureSEC source: 0000950170-24-002607 · ownership.xml · nonDerivative · entry 1 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,178 F1 · shares: Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). F2 · balance_after: Includes (i) 6,025 shares of Common Stock issued in connection with the vesting of RSUs on January 1, 2024, and (ii) 13,525 shares of Common Stock that will be issued in connection with the vesting of RSUs on January 15, 2024, subject to the Reporting Person's continued service through such date. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 18:33 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | Not disclosed Strike: $1.96 | Not disclosed |
DisclosureSEC source: 0000899243-23-019162 · doc4.xml · derivative · entry 4 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,668 Underlying: Common Stock · 6,000 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the exercise of stock options awarded under the Issuer's equity incentive plan. F3 · price: The option vests and becomes exercisable in 48 substantially equal monthly installments commencing June 24, 2021. F3 · derivative.exercise_date: The option vests and becomes exercisable in 48 substantially equal monthly installments commencing June 24, 2021. F1 · derivative.underlying_shares: Reflects the exercise of stock options awarded under the Issuer's equity incentive plan. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 18:33 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Exercise / conversionStock Option (Right to Buy) · Derivative | 31,668 | Not disclosed Strike: $1.96 | Not disclosed |
DisclosureSEC source: 0000899243-23-019162 · doc4.xml · derivative · entry 3 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 31,668 shares Expires 2030-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the exercise of stock options awarded under the Issuer's equity incentive plan. F3 · price: The option vests and becomes exercisable in 48 substantially equal monthly installments commencing June 24, 2021. F2 · derivative.exercise_date: The option vested and became exercisable as to 25% of the underlying securities on March 31, 2021, and continues to vest and become exercisable in 36 equal monthly installments thereafter. F1 · derivative.underlying_shares: Reflects the exercise of stock options awarded under the Issuer's equity incentive plan. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 18:33 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Exercise / conversionCommon Stock | 6,000 | $1.96 | $11,760.00 |
DisclosureSEC source: 0000899243-23-019162 · doc4.xml · nonDerivative · entry 2 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the exercise of stock options awarded under the Issuer's equity incentive plan. Read SEC document |
| September 14, 2023 Filed Sep 15, 2023 18:33 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Exercise / conversionCommon Stock | 31,668 | $1.96 | $62,069.28 |
DisclosureSEC source: 0000899243-23-019162 · doc4.xml · nonDerivative · entry 1 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the exercise of stock options awarded under the Issuer's equity incentive plan. Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 06:15 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantStock Option (Right to Buy) · Derivative | 69,100 | $0.00 Strike: $9.78 | $0.00 |
DisclosureSEC source: 0000899243-23-009243 · doc4.xml · derivative · entry 2 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,100 Underlying: Common Stock · 69,100 shares Expires 2033-03-16 F3 · shares: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. F3 · derivative.exercise_date: Reflects a grant of stock options ("Options") made to the Reporting Person under the 2021 Plan. The Options vest and become exercisable in 48 equal monthly installments with the first installment vesting commencing on January 1, 2023 through January 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 16, 2023 Filed Mar 21, 2023 06:15 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 54,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-009243 · doc4.xml · nonDerivative · entry 1 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,424 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments from January 15, 2024 through January 15, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). F2 · balance_after: Reflects shares of Common Stock beneficially owned by the Reporting Person as of the date hereof, excluding RSUs that do not vest within 60 days of this filing pursuant to Rule 13d-3(d)(1)(i). Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 06:30 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Tax withholdingCommon Stock | 2,393 | $12.38 | $29,622.95 |
DisclosureSEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 5 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,424 F6 · shares: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of RSUs. F7 · price: Reflects the weighted average price at which the shares were sold. The shares were sold in multiple transactions at prices ranging from $12.16 to $12.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 06:30 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 24,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 4 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,817 F4 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date. F5 · balance_after: Includes 6,025 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant. Read SEC document |
| November 18, 2022 Filed Jan 5, 2023 06:30 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 3,128 | $6.79 | $21,245.38 |
DisclosureSEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 3 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,792 F3 · shares: Reflects shares purchased under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| March 25, 2022 Filed Jan 5, 2023 06:30 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Exercise / conversionCommon Stock | 3,666 | $1.96 | $7,185.36 |
DisclosureSEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 2 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Reflects the exercise of stock options awarded under the Issuer's equity incentive plan. Read SEC document |
| February 26, 2022 Filed Jan 5, 2023 06:30 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Exercise / conversionCommon Stock | 16,666 | $1.96 | $32,665.36 |
DisclosureSEC source: 0000899243-23-000827 · doc4.xml · nonDerivative · entry 1 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the exercise of stock options awarded under the Issuer's equity incentive plan. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:05 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantStock Option (Right to Buy) · Derivative | 96,400 | $0.00 Strike: $17.52 | $0.00 |
DisclosureSEC source: 0000899243-22-005823 · doc4.xml · derivative · entry 2 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,400 Underlying: Common Stock · 96,400 shares Expires 2032-02-09 F3 · derivative.exercise_date: The options vest and become exercisable in 48 substantially equal monthly installments with the first installment vesting on February 1, 2022. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 16:05 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantRestricted Stock Units · Derivative | 24,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-005823 · doc4.xml · derivative · entry 1 Park Sam Boong · CIK 0001871706 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,100 Underlying: Common Stock · 24,100 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The Restricted Stock Units vest as to 25% on each of January 1, 2023; January 1, 2024; January 1, 2025 and January 1, 2026. The Restricted Stock Units have no expiration date. F2 · derivative.expiration_date: The Restricted Stock Units vest as to 25% on each of January 1, 2023; January 1, 2024; January 1, 2025 and January 1, 2026. The Restricted Stock Units have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.